Shares of CBIZ, Inc. (NYSE:CBZ) have been assigned a consensus broker rating score of 1.00 (Strong Buy) from the one analysts that provide coverage for the stock, Zacks Investment Research reports. One analyst has rated the stock with a strong buy recommendation.
Zacks has also assigned CBIZ an industry rank of 35 out of 256 based on the ratings given to its competitors.
Several research analysts have issued reports on the company. Zacks Investment Research upgraded CBIZ from a “hold” rating to a “buy” rating and set a $23.00 price objective for the company in a research report on Friday, February 15th. ValuEngine lowered CBIZ from a “buy” rating to a “hold” rating in a report on Tuesday, March 12th.
CBIZ (NYSE:CBZ) last released its quarterly earnings data on Thursday, April 25th. The business services provider reported $0.67 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.68 by ($0.01). The business had revenue of $270.00 million during the quarter, compared to analysts’ expectations of $278.78 million. CBIZ had a return on equity of 10.52% and a net margin of 6.82%. The company’s revenue was up 1.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.64 EPS. As a group, sell-side analysts anticipate that CBIZ will post 1.19 EPS for the current year.
In other CBIZ news, Director Todd J. Slotkin sold 3,500 shares of the company’s stock in a transaction on Friday, March 15th. The stock was sold at an average price of $20.14, for a total value of $70,490.00. Following the sale, the director now owns 40,375 shares of the company’s stock, valued at $813,152.50. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Joseph S. Dimartino sold 3,488 shares of the company’s stock in a transaction on Friday, March 1st. The shares were sold at an average price of $20.63, for a total value of $71,957.44. The disclosure for this sale can be found here. Insiders sold 17,242 shares of company stock worth $350,049 in the last three months. 7.40% of the stock is owned by corporate insiders.
Institutional investors have recently bought and sold shares of the business. Meeder Asset Management Inc. grew its holdings in CBIZ by 121.7% in the fourth quarter. Meeder Asset Management Inc. now owns 1,377 shares of the business services provider’s stock valued at $27,000 after purchasing an additional 756 shares during the last quarter. Quantamental Technologies LLC acquired a new stake in shares of CBIZ during the fourth quarter valued at $43,000. Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in shares of CBIZ by 54.9% during the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,839 shares of the business services provider’s stock valued at $76,000 after acquiring an additional 1,361 shares during the last quarter. Great West Life Assurance Co. Can boosted its stake in shares of CBIZ by 63.1% during the first quarter. Great West Life Assurance Co. Can now owns 6,686 shares of the business services provider’s stock valued at $135,000 after acquiring an additional 2,586 shares during the last quarter. Finally, O Shaughnessy Asset Management LLC boosted its stake in shares of CBIZ by 484.1% during the fourth quarter. O Shaughnessy Asset Management LLC now owns 9,316 shares of the business services provider’s stock valued at $184,000 after acquiring an additional 7,721 shares during the last quarter. 86.75% of the stock is currently owned by institutional investors.
CBIZ Company Profile
CBIZ, Inc provides professional business services, products, and solutions that help its clients in managing finances and employees. It offers its services through three groups: Financial Services, Benefits and Insurance Services, and National Practices. The Financial Services group provides accounting and tax, government healthcare consulting, financial advisory, valuation, and risk and advisory services.
Featured Article: Call Option
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for CBIZ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CBIZ and related companies with MarketBeat.com's FREE daily email newsletter.